Glenmark gets FDA OK for generic Vytorin

Press enter to search
Close search
Open Menu

Glenmark gets FDA OK for generic Vytorin

By Sandra Levy - 07/31/2019
Glenmark has received the Food and Drug Administration’s clearance for ezetimibe and simvastatin tablets in dosage strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg.

The product is the generic of MSD International’s Vytorin tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg.

It is used along with diet to lower the level of bad cholesterol (LDL); increase the level of good cholesterol (HDL); and lower the level of fat in the blood (triglycerides).

Vytorin tablets had a market value of approximately $92.4 million for the 12 month period ended April 2019, according to IQVIA.

RELATED TOPICS